Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function

Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function

<strong>Background</strong> The capsular group B meningococcal vaccine (4CMenB) is recommended for children with complement deficiencies, asplenia and splenic dysfunction, however, data on the immunogenicity of 4CMenB in these ‘at-risk’ children are missing. <strong>Methods</st...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Martinón-Torres, FL, Bernatowska, E, Shcherbina, A, Esposito, S, Szenborn, L, Marti, MC, Hughes, S, Faust, SN, Yu, LM, D’Agostino, D, Calabresi, M, Toneatto, D, Snape, MD
Format:	Journal article
Veröffentlicht:	American Academy of Pediatrics 2018

Ähnliche Einträge

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
von: Snape, MD, et al.
Veröffentlicht: (2010)

Meningitis and meningococcal septicaemia.
von: Pollard, A, et al.
Veröffentlicht: (1998)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
von: Snape, MD, et al.
Veröffentlicht: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
von: Snape, M, et al.
Veröffentlicht: (2013)

Meningitis and meningococcal septicaemia - Extended review
von: Pollard, A, et al.
Veröffentlicht: (1998)

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
von: Gossger, N, et al.
Veröffentlicht: (2012)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
von: Read, R, et al.
Veröffentlicht: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
von: Read, R, et al.
Veröffentlicht: (2014)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
von: Perrett, K, et al.
Veröffentlicht: (2009)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
von: Snape, MD, et al.
Veröffentlicht: (2008)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
von: So, N, et al.
Veröffentlicht: (2018)

Emergency management of meningococcal disease: eight years on.
von: Pollard, A, et al.
Veröffentlicht: (2007)

Isolated splenic tuberculosis.
von: Singh, B, et al.
Veröffentlicht: (2005)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.
von: Snape, MD, et al.
Veröffentlicht: (2013)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial
von: Snape, MD, et al.
Veröffentlicht: (2013)

Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.
von: Ramasamy, M, et al.
Veröffentlicht: (2014)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
von: Collins, C, et al.
Veröffentlicht: (2005)

Splenic size in homozygous alpha+ thalassaemia.
von: Williams, T, et al.
Veröffentlicht: (1998)

Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens
von: Read, Benjamin J, et al.
Veröffentlicht: (2023)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
von: Pace, D, et al.
Veröffentlicht: (2015)

Meningococcal polysaccharide-protein conjugate vaccines.
von: Snape, MD, et al.
Veröffentlicht: (2005)

Ceftriaxone drug alert: no longer for first line use in meningococcal sepsis.
von: Faust, SN, et al.
Veröffentlicht: (2008)

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
von: Sadarangani, M, et al.
Veröffentlicht: (2017)

A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group b meningococcal vaccine
von: Rajan, M, et al.
Veröffentlicht: (2022)

Splenic mesenchyme-to-epithelial transition in islet neogenesis
von: Robertson, S, et al.
Veröffentlicht: (2009)

Rebuilding the Edge: The Case of the Sulmona–Carpinone Railway and the Town of Pettorano sul Gizio
von: D'Agostino, Ginevra
Veröffentlicht: (2022)

Chomsky's system of ideas /
von: D'Agostino, Fred
Veröffentlicht: (1986)

Advanced plasma technology /
von: d'Agostino, Riccardo
Veröffentlicht: (2008)

Rich like them : my door-to-door search for the secrets of wealth in America's richest neighborhoods /
von: D'agostino, Ryan
Veröffentlicht: (2009)

Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.
von: Jongerius, I, et al.
Veröffentlicht: (2013)

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months.
von: McQuaid, F, et al.
Veröffentlicht: (2015)

Endovascular treatment of splenic and renal aneurysms.
von: Vallina-Victorero Vazquez, M, et al.
Veröffentlicht: (2009)

Splenic phagocytic function in patients with inflammatory bowel disease.
von: Jewell, D, et al.
Veröffentlicht: (1981)

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
von: Davis, K, et al.
Veröffentlicht: (2021)

A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.
von: Arnold, D, et al.
Veröffentlicht: (2009)

Control of invasive meningococcal disease: is it achievable?
von: Marshall, H, et al.
Veröffentlicht: (2016)

Response of the splenic dendritic cell population to malaria infection.
von: Leisewitz, A, et al.
Veröffentlicht: (2004)

Emergency management of meningococcal disease: eight years on
von: Pollard, A, et al.
Veröffentlicht: (2007)

Dynamic alteration in splenic function during acute falciparum malaria.
von: Looareesuwan, S, et al.
Veröffentlicht: (1987)

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
von: Buttery, J, et al.
Veröffentlicht: (2005)